Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Azithromycin Capsule
DRUG
2 trials
Sponsors
Cadrock Pty. Ltd.
, University of Oxford
Conditions
COVID-19
Chlamydophila Pneumoniae Infections
Coronary Heart Disease
Phase 2
Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart Disease
Terminated
NCT03618108
Cadrock Pty. Ltd.
Chlamydophila Pneumoniae Infections, Coronary Heart Disease
Start: 2018-04-04
End: 2020-11-30
Updated: 2021-08-02
Phase 3
A Multicentre Open-label Two-arm Randomised Superiority Clinical Trial of Azithromycin Versus Usual Care In Ambulatory COVID19 (ATOMIC2)
Completed
NCT04381962
University of Oxford
COVID-19
Start: 2020-06-03
End: 2021-04-20
Updated: 2021-05-06
Related Papers
S50 A randomised clinical trial of azithromycin versus standard care in ambulatory COVID-19 – the ATOMIC2 trial
2021-11-01
4 citations
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial.
2021-07-09
58 citations
A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial.
2020-08-17
22 citations